TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Sophie Grabar, Véronique Della-Valle et al.|Blood|2009Cited by 270
In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosisYann-Érick Claessens, Michaëla Fontenay, Didier Bouscary et al.|Blood|2002Cited by 144